indazoles has been researched along with pyrimidine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, KP; Lingaiah, BP; Murthy, US; Narsaiah, B; Yakaiah, T | 1 |
| Behm, DJ; Bentley, R; Doe, CP; Dowdell, SE; Dul, E; Elkins, PA; Evans, C; Goodman, KB; Hu, E; Jolivette, LJ; Khandekar, SS; Kirkpatrick, RB; Lee, D; Sehon, CA; Semus, SF; Smith, GK; Viet, AQ; Wang, GZ; Wright, LL; Yi, T | 1 |
| Kim, D; Kwon, A; Lee, BY; Min, KH; Nguyen, HK; Song, J; Suh, W; Yoo, J | 1 |
3 other study(ies) available for indazoles and pyrimidine
| Article | Year |
|---|---|
GdCl(3) catalysed Grieco condensation: a facile approach for the synthesis of novel pyrimidine and annulated pyrimidine fused indazole derivatives in single pot under mild conditions and their anti-microbial activity.
Topics: Anti-Bacterial Agents; Antifungal Agents; Catalysis; Gadolinium; Indazoles; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Pyrimidines | 2008 |
Potent, selective and orally bioavailable dihydropyrimidine inhibitors of Rho kinase (ROCK1) as potential therapeutic agents for cardiovascular diseases.
Topics: Adenosine Triphosphate; Administration, Oral; Aldehydes; Animals; Cardiovascular Diseases; Crystallography, X-Ray; Indazoles; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Pyrimidines; Rats; rho-Associated Kinases; Structure-Activity Relationship | 2008 |
Structure-Activity Relationship of Indole-Tethered Pyrimidine Derivatives that Concurrently Inhibit Epidermal Growth Factor Receptor and Other Angiokinases.
Topics: Angiogenesis Inhibitors; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; ErbB Receptors; Human Umbilical Vein Endothelial Cells; Humans; Indazoles; Indoles; Inhibitory Concentration 50; Lung Neoplasms; Molecular Docking Simulation; Neovascularization, Pathologic; Protein Kinase Inhibitors; Protein Kinases; Pyrimidines; Structure-Activity Relationship; Sulfonamides; Vascular Endothelial Growth Factor A | 2015 |